Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...

Early Phase I data showed inhaled londamocitinib reduced airway inflammation in mild asthma with good tolerability. Learn ...

A woman has praised an urgent treatment centre (UTC) after it discovered she had a heart condition. Staff at the Corby UTC in ...

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...

Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...

This study shows that specific ratios of circulating sphingolipids to steroids can predict the risk of future asthma ...

A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...

The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe ...

The American College of Chest Physicians recently released a new clinical guideline on biologic management in severe asthma.

The American College of Chest Physicians released a new clinical guideline on biologic management in severe asthma containing seven evidence-based recommendations.

Spiro Medical, which debuted last year, reeled in $67 million in series A funding it plans to use to develop its novel treatment for asthma.

Statins were linked to a decreased acute exacerbation risk in mild asthma and had a significant protective effect in Black patients and patients with obesity. Statins were associated with a decreased ...